A Systematic Review of the Factors Affecting Accuracy of SUV Measurements

被引:495
作者
Adams, Michael C. [2 ]
Turkington, Timothy G. [1 ,2 ]
Wilson, Joshua M. [1 ]
Wong, Terence Z. [1 ,3 ]
机构
[1] Duke Univ, Med Ctr, Grad Program Med Phys, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA
关键词
blood glucose; body weight; partial volume effect; PET; quantification; reconstruction parameters; scanner; standardized uptake value (SUV); uptake time; STANDARDIZED UPTAKE VALUES; FDG-PET; F-18-FDG PET; BODY-WEIGHT; ATTENUATION CORRECTION; IMAGE-RECONSTRUCTION; ROI DEFINITION; NORMAL-TISSUES; BREAST-CANCER; LUNG-CANCER;
D O I
10.2214/AJR.10.4923
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. There is growing interest in using PET/CT for evaluating early response to therapy in cancer treatment. Although widely available and convenient to use, standardized uptake value (SUV) measurements can be influenced by a variety of biologic and technologic factors. Many of these factors can be addressed with close attention to detail and appropriate quality control. This article will review factors potentially affecting SUV measurements and provide recommendations on ways to minimize when using serial PET to assess early response to therapy. CONCLUSION. Scanner and reconstruction parameters can significantly affect SUV measurements. When using serial SUV measurements to assess early response to therapy, imaging should be performed on the same scanner using the same image acquisition and reconstruction protocols. In addition, attention to detail is required for accurate determination of the administered radiopharmaceutical dose.
引用
收藏
页码:310 / 320
页数:11
相关论文
共 52 条
[1]   Quantification in PET [J].
Acton, PD ;
Zhuang, HM ;
Alavi, A .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2004, 42 (06) :1055-+
[2]  
Avril N, 1997, J NUCL MED, V38, P1186
[3]   18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response [J].
Ben-Haim, Simona ;
Ell, Peter .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (01) :88-99
[4]   Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas:: Interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors [J].
Benz, Matthias R. ;
Evilevitch, Vladimir ;
Allen-Auerbach, Martin S. ;
Eilber, Fritz C. ;
Phelps, Michael E. ;
Czernin, Johannes ;
Weber, Wolfgang A. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (07) :1038-1046
[5]  
Boellaard R, 2004, J NUCL MED, V45, P1519
[6]   The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials [J].
Boellaard, Ronald ;
Oyen, Wim J. G. ;
Hoekstra, Corneline J. ;
Hoekstra, Otto S. ;
Visser, Eric P. ;
Willemsen, Antoon T. ;
Arends, Bertjan ;
Verzijlbergen, Fred J. ;
Zijlstra, Josee ;
Paans, Anne M. ;
Comans, Emile F. I. ;
Pruim, Jan .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (12) :2320-2333
[7]   Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements [J].
Bunyaviroch, Tira ;
Turkington, Timothy G. ;
Wong, Terence Z. ;
Wilson, John W. ;
Colsher, James G. ;
Coleman, R. Edward .
MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (02) :107-113
[8]   Quantitative techniques in 18FDG PET scanning in oncology [J].
Castell, F. ;
Cook, G. J. R. .
BRITISH JOURNAL OF CANCER, 2008, 98 (10) :1597-1601
[9]   Increasing Uptake Time in FDG-PET: Standardized Uptake Values in Normal Tissues at 1 versus 3 h [J].
Chin, Bennett B. ;
Green, Edward D. ;
Turkington, Timothy G. ;
Hawk, Thomas C. ;
Coleman, R. Edward .
MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (02) :118-122
[10]   Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis [J].
Eary, JF ;
O'Sullivan, F ;
Powitan, Y ;
Chandhury, KR ;
Vernon, C ;
Bruckner, JD ;
Conrad, EU .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (09) :1149-1154